ADUS:NSD-Addus HomeCare Corporation (USD)

COMMON STOCK | Medical Care Facilities | NSD

Last Closing Price

USD 84.62

Change

0.00 (0.00)%

Market Cap

USD 1.36B

Volume

0.08M

Avg Analyst Target

USD 109.25 (+29.11%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


ADUS Stock Forecast & Price:
Based on the Addus HomeCare Corporation stock forecasts from 4 analysts, the average analyst target price for Addus HomeCare Corporation is USD 109.25 over the next 12 months. Addus HomeCare Corporation’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Addus HomeCare Corporation is Slightly Bullish , which is based on 5 positive signals and 4 negative signals. At the last closing, Addus HomeCare Corporation’s stock price was USD 84.62. Addus HomeCare Corporation’s stock price has changed by -2.77% over the past week, +2.50% over the past month and -4.80% over the last year.

About Addus HomeCare Corporation (ADUS:NSD)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-07-04 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ACHC Acadia Healthcare Company Inc

N/A

USD6.48B 25.38 15.48
LHCG LHC Group

N/A

USD4.81B 48.15 24.66
ENSG The Ensign Group Inc

N/A

USD4.20B 21.94 16.15
AMED Amedisys Inc

N/A

USD3.61B 18.08 12.08
SGRY Surgery Partners Inc

N/A

USD2.81B 63.00 13.11
PRSC The Providence Service Corpora..

N/A

USD2.21B 74.23 15.08
AMEH Apollo Medical Holdings Inc

N/A

USD1.74B 23.54 17.85
TVTY Tivity Health Inc

N/A

USD1.62B 19.06 12.00
HCSG Healthcare Services Group Inc

N/A

USD1.30B 40.93 18.99
CCRN Cross Country Healthcare Inc

N/A

USD0.81B 4.50 4.57

ETFs Containing ADUS

Symbol Name Weight Mer Price(Change) Market Cap
SBM ProShares Short Basic Mat.. 7.23 % 0.95 %

N/A

USD1.85M
SMN ProShares UltraShort Basi.. 7.23 % 0.95 %

N/A

USD2.43M
ZPDM:F SPDR S&P U.S. Materials S.. 4.41 % 0.15 %

+0.57 (+1.73%)

USD0.10B
ZPDM:XETRA SPDR S&P U.S. Materials S.. 4.41 % 0.15 %

+0.14 (+0.41%)

USD0.10B
2B7B:XETRA iShares S&P 500 Materials.. 4.34 % 0.15 %

+0.03 (+0.37%)

USD0.18B
JHMA John Hancock Multifactor .. 3.66 % 0.40 %

N/A

USD0.02B
SXLB:LSE SPDR S&P U.S. Materials S.. 3.57 % 0.15 %

+0.28 (+0.82%)

USD0.10B
XLB Materials Select Sector S.. 3.45 % 0.10 %

N/A

USD6.37B
IMSU:LSE iShares S&P 500 Materials.. 3.44 % 0.15 %

+1.38 (+0.22%)

USD0.18B
IUMS:LSE iShares S&P 500 Materials.. 3.44 % 0.15 %

+0.06 (+0.72%)

USD0.18B
UYM ProShares Ultra Basic Mat.. 2.96 % 0.95 %

N/A

USD0.06B
VAW Vanguard Materials Index .. 2.74 % 0.10 %

N/A

USD4.76B
FMAT Fidelity® MSCI Materials.. 2.64 % 0.08 %

N/A

USD0.43B
VMO:CA Vanguard Global Momentum .. 0.68 % 0.37 %

+0.16 (+0.41%)

USD0.06B
VVAL:LSE Vanguard Global Value Fac.. 0.54 % 0.00 %

N/A

USD0.24B
IMCB iShares Morningstar Mid-C.. 0.00 % 0.04 %

N/A

N/A
BIV Vanguard Intermediate-Ter.. 0.00 % 0.04 %

N/A

USD33.64B
VCLT Vanguard Long-Term Corpor.. 0.00 % 0.04 %

N/A

USD4.81B
VCSH Vanguard Short-Term Corpo.. 0.00 % 0.04 %

N/A

USD47.91B
BLV Vanguard Long-Term Bond I.. 0.00 % 0.04 %

N/A

USD8.64B
VCIT Vanguard Intermediate-Ter.. 0.00 % 0.04 %

N/A

USD44.39B
SCHZ Schwab U.S. Aggregate Bon.. 0.00 % 0.04 %

N/A

USD7.73B
FAB First Trust Multi Cap Val.. 0.00 % 0.69 %

N/A

USD0.19B
BSV Vanguard Short-Term Bond .. 0.00 % 0.04 %

N/A

USD38.54B
IDAT Ishares Trust - Cloud Dat.. 0.00 % 0.47 %

N/A

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -9.51% 78% C+ 66% D
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.51% 78% C+ 65% D
Trailing 12 Months  
Capital Gain -4.80% 85% B 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.80% 85% B 71% C-
Trailing 5 Years  
Capital Gain 126.86% 64% D 86% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 126.86% 64% D 85% B
Average Annual (5 Year Horizon)  
Capital Gain 25.95% 62% D- 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.95% 62% D- 81% B-
Risk Return Profile  
Volatility (Standard Deviation) 36.70% 62% D- 43% F
Risk Adjusted Return 70.71% 76% C 92% A-
Market Capitalization 1.36B 70% C- 75% C
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 29.90 44% F 28% F
Price/Book Ratio 2.32 65% D 37% F
Price / Cash Flow Ratio 34.44 9% F 8% F
EV/EBITDA 18.80 30% F 15% F
Management Effectiveness  
Return on Equity 8.01% 61% D- 61% D-
Return on Invested Capital 6.91% 50% F 67% D+
Return on Assets 4.95% 65% D 80% B-
Debt to Equity Ratio 38.46% 60% D- 45% F
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio 4.87 65% D 35% F
Short Percent 2.35% 74% C 57% F
Beta 0.87 63% D 66% D
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.